Brainstorm Cell Therapeutics Company
Brainstorm is a developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders.
Technology:
Regenerative Medicine
Industry:
Cell Therapy
Headquarters:
New York, New York, United States
Founded Date:
2000
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
5
Total Funding:
$51.6M
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Register and Claim Ownership